Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.39 USD
-0.01 (-0.71%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $1.38 -0.01 (-0.72%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Atossa Genetics Inc. [ATOS]
Reports for Purchase
Showing records 1 - 20 ( 61 total )
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
2Q24 Recap: Phase 2 Karisma Topline Data and I-SPY 2 Data on Track for 2H24
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Z-endoxifen + Abemaciclib Study Protocol Changed to Increase Enrollment and Dose
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
1Q24 Recap: I-SPY 2 Data Expected in 2H24; EVANGELINE Study Enrollment Continues
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
I-SPY 2 Trial to Add a Z-endoxifen + Abemaciclib Arm for Treatment of Neoadjuvant Breast Cancer
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
EVANGELINE Data From 40 mg Z-Endoxifen Dose Increase Our Confidence in 80 mg Dose
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
4Q23 Recap: Two Key Z-Endoxifen Data Readouts Expected in 2H24
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Spotlighting Tamoxifen''s Active Metabolite, Endoxifen, as a Standalone and Superior Drug; Initiating at Buy and $4 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BODNAR E
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Multiple opportunities to address breast health
Provider: Edison Investment Research Limited
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Atossa raises $13.4m in rights offering
Provider: EDISON INVESTMENT RESEARCH LIMITED
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Atossa raises $13.4m in rights offering
Provider: EDISON INVESTMENT RESEARCH LIMITED
Analyst: HEMAMI P
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Atossa Genetics Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G